sulfamethoxypyridazine has been researched along with indomethacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Fry, L; Griffiths, CE; Leonard, JN | 1 |
| Schrogie, JJ; Solomon, HM; Williams, D | 1 |
1 trial(s) available for sulfamethoxypyridazine and indomethacin
| Article | Year |
|---|---|
Dermatitis herpetiformis exacerbated by indomethacin.
Topics: Adult; Aged; Dapsone; Dermatitis Herpetiformis; Female; Humans; Indomethacin; Male; Middle Aged; Sulfamethoxypyridazine | 1985 |
2 other study(ies) available for sulfamethoxypyridazine and indomethacin
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.
Topics: Benzene Derivatives; Binding Sites; Butyrates; Carbon Isotopes; Chlorine; Dialysis; Fatty Acids, Nonesterified; Humans; Indomethacin; Phenylbutazone; Protein Binding; Serum Albumin; Stearic Acids; Sulfamethoxypyridazine; Tolbutamide; Warfarin | 1968 |